BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19175039)

  • 21. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
    Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
    Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hyperthermia on Hsp27 (HSPB1), Hsp72 (HSPA1A) and DNA repair proteins hMLH1 and hMSH2 in human colorectal cancer hMLH1-deficient and hMLH1-proficient cell lines.
    Nadin SB; Cuello-Carrión FD; Sottile ML; Ciocca DR; Vargas-Roig LM
    Int J Hyperthermia; 2012; 28(3):191-201. PubMed ID: 22515340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy.
    Fernandes AM; Ramos-Jorge ML; Cardoso SV; Loyola AM; Mesquita RA; Aguiar MC
    J Oral Pathol Med; 2008 Oct; 37(9):543-8. PubMed ID: 18331286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
    Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D
    Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma.
    Peiró G; Diebold J; Mayr D; Baretton GB; Kimmig R; Schmidt M; Löhrs U
    Mod Pathol; 2001 Aug; 14(8):777-83. PubMed ID: 11504837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast.
    Son BH; Ahn SH; Ko CD; Ka IW; Gong GY; Kim JC
    Breast J; 2004; 10(1):20-6. PubMed ID: 14717755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
    Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
    Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study the value of screening hereditary nonpolyposis colorectal cancer kindreds by detecting the expression of hMLH1/hMSH2 with tissue microarray].
    Jin HY; Ding YJ; Geng JX; Liu F; Yang BL; Huang SL; Ding SQ; Ge YS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):67-9. PubMed ID: 17253179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of DNA mismatch repair in acquired resistance to cisplatin.
    Aebi S; Kurdi-Haidar B; Gordon R; Cenni B; Zheng H; Fink D; Christen RD; Boland CR; Koi M; Fishel R; Howell SB
    Cancer Res; 1996 Jul; 56(13):3087-90. PubMed ID: 8674066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
    Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
    Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of DNA mismatch repair in platinum drug resistance.
    Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
    Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
    Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
    Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
    Li M; Zhao ZW
    Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.
    Tian H; Yan L; Xiao-Fei L; Hai-Yan S; Juan C; Shan K
    Clin Epigenetics; 2019 Oct; 11(1):153. PubMed ID: 31666131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt.
    Helal TE; Khamis NS; El-Sharkawy TM; Nada OH; Radwan NA
    APMIS; 2010 Dec; 118(12):934-40. PubMed ID: 21091774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma.
    Stoehr C; Burger M; Stoehr R; Bertz S; Ruemmele P; Hofstaedter F; Denzinger S; Wieland WF; Hartmann A; Walter B
    Pathobiology; 2012; 79(3):162-8. PubMed ID: 22378480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
    Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
    Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression difference of DNA mismatch repair gene hMLH1 and hMSH2 between schistosomiasis-associated colorectal cancer and sporadic colorectal cancer].
    Chen Y; Liu Z; Qian J; Feng H; Li D; Fan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jan; 19(1):75-9. PubMed ID: 26797844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment.
    Vageli DP; Zaravinos A; Daniil Z; Dahabreh J; Doukas SG; Spandidos DA; Gourgoulianis KI; Koukoulis GK
    Int J Biol Markers; 2013 Jan; 27(4):e400-4. PubMed ID: 22865300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.